MetLife Investment Management’s Usana Health Sciences USNA Stock Holding History

MetLife Investment Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$102K	Hold	5,819	–	–	﹤0.01%	2535
2025 Q4	$114K	Hold	5,819	–	–	﹤0.01%	2547
2025 Q3	$160K	Sell	5,819 -882	-13%	-$27.1K	﹤0.01%	2434
2025 Q2	$205K	Hold	6,701	–	–	﹤0.01%	2177
2025 Q1	$181K	Sell	6,701 -170	-2%	-$5.38K	﹤0.01%	2256
2024 Q4	$247K	Sell	6,871 -83	-1%	-$3.1K	﹤0.01%	2194
2024 Q3	$264K	Hold	6,954	–	–	﹤0.01%	2145
2024 Q2	$315K	Buy	6,954 +1,187	+21%	+$54.6K	﹤0.01%	1980
2024 Q1	$280K	Hold	5,767	–	–	﹤0.01%	1996
2023 Q4	$309K	Hold	5,767	–	–	﹤0.01%	1977
2023 Q3	$338K	Hold	5,767	–	–	﹤0.01%	1868
2023 Q2	$364K	Hold	5,767	–	–	﹤0.01%	1903
2023 Q1	$363K	Hold	5,767	–	–	﹤0.01%	1854
2022 Q4	$307K	Hold	5,767	–	–	﹤0.01%	1969
2022 Q3	$323K	Hold	5,767	–	–	﹤0.01%	1953
2022 Q2	$417K	Sell	5,767 -1,321	-19%	-$98.4K	﹤0.01%	1796
2022 Q1	$563K	Buy	7,088 +2,561	+57%	+$231K	﹤0.01%	1698
2021 Q4	$458K	Hold	4,527	–	–	﹤0.01%	1553
2021 Q3	$417K	Hold	4,527	–	–	﹤0.01%	1632
2021 Q2	$464K	Hold	4,527	–	–	﹤0.01%	1611
2021 Q1	$442K	Hold	4,527	–	–	﹤0.01%	1601
2020 Q4	$349K	Hold	4,527	–	–	﹤0.01%	1675
2020 Q3	$333K	Sell	4,527 -1,068	-19%	-$85.7K	﹤0.01%	1578
2020 Q2	$411K	Hold	5,595	–	–	﹤0.01%	1489
2020 Q1	$323K	Hold	5,595	–	–	﹤0.01%	1448
2019 Q4	$439K	Sell	5,595 -1,259	-18%	-$92.8K	﹤0.01%	1537
2019 Q3	$469K	Hold	6,854	–	–	0.01%	1451
2019 Q2	$544K	Buy	6,854 +1,248	+22%	+$99K	0.01%	1431
2019 Q1	$470K	Hold	5,606	–	–	0.01%	1482
2018 Q4	$660K	Hold	5,606	–	–	0.01%	1201
2018 Q3	$676K	Hold	5,606	–	–	0.01%	1343
2018 Q2	$646K	Hold	5,606	–	–	0.01%	1259
2018 Q1	$482K	Hold	5,606	–	–	0.01%	1393
2017 Q4	$415K	Buy	+5,606	New	+$375K	﹤0.01%	1509

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's USNA Position: Q1 2026 in Review

MetLife Investment Management held its Usana Health Sciences (USNA) position steady in Q1 2026 at 5,819 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2535.

MetLife Investment Management first reported a position in USNA in Q4 2017 and has held it in 34 quarters since. The position peaked at $676K in Q3 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

MetLife Investment Management held 5,819 shares of Usana Health Sciences worth $102K as of Q1 2026.
MetLife Investment Management left its Usana Health Sciences share count unchanged in Q1 2026.
Usana Health Sciences made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2535 holding.
MetLife Investment Management first reported a position in Usana Health Sciences in Q4 2017 and has held it in 34 quarters since.
MetLife Investment Management's Usana Health Sciences position peaked at $676K in Q3 2018.
139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.